GSK3β Regulates Differentiation and Growth Arrest in Glioblastoma

PLoS ONE

Volumn 4, Issue 10, 2009, Pages

  Korur, Serdar ^a   Huber, Roland M ^a   Sivasankaran, Balasubramanian ^a   Petrich, Michael ^a   Morin Jr , Pier ^b   Hemmings, Brian A ^b   Merlo, Adrian ^a   Lino, Maria Maddalena ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BMI1 PROTEIN, HUMAN; CD133 ANTIGEN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; NUCLEAR PROTEIN; ONCOPROTEIN; PEPTIDE; REPRESSOR PROTEIN; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; BRAIN TUMOR; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; DNA MICROARRAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GLIOBLASTOMA; HUMAN; METABOLISM; METHODOLOGY; PHENOTYPE;

ANTIGENS, CD; APOPTOSIS; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; GLYCOGEN SYNTHASE KINASE 3; GLYCOPROTEINS; HUMANS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDES; PHENOTYPE; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; RNA, SMALL INTERFERING;

EID: 77949268513     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007443     Document Type: Article

References (53)

1. Visvader JE, Lindeman GJ, (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768.
2. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al.(2004) Identification of human brain tumour initiating cells. Nature 432: 396-401.
3. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, et al.(2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828.
4. Dean M, Fojo T, Bates S, (2005) Tumour stem cells and drug resistance. Nat Rev Cancer 5: 275-284.
5. Joo KM, Kim SY, Jin X, Song SY, Kong DS, et al.(2008) Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest 88: 808-815.
6. Merlo A, (2003) Genes and pathways driving glioblastomas in humans and murine disease models. Neurosurg Rev 26: 145-158.
7. Newton HB, (1994) Primary brain tumors: review of etiology, diagnosis and treatment. Am Fam Physician 49: 787-797.
8. Newton HB, (2004) Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 3: brain tumor invasiveness. Expert Rev Anticancer Ther 4: 803-821.
9. Leung C, Lingbeek M, Shakhova O, Liu J, Tanger E, et al.(2004) Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 428: 337-341.
10. Orlando V, (2003) Polycomb, epigenomes, and control of cell identity. Cell 112: 599-606.
11. Nowak K, Kerl K, Fehr D, Kramps C, Gessner C, et al.(2006) BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas. Nucleic Acids Res 34: 1745-1754.
12. Valk-Lingbeek ME, Bruggeman SW, van Lohuizen M, (2004) Stem cells and cancer; the polycomb connection. Cell 118: 409-418.
13. Park IK, Morrison SJ, Clarke MF, (2004) Bmi1, stem cells, and senescence regulation. J Clin Invest 113: 175-179.
14. Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, et al.(2003) Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425: 962-967.
15. Zencak D, Lingbeek M, Kostic C, Tekaya M, Tanger E, et al.(2005) Bmi1 loss produces an increase in astroglial cells and a decrease in neural stem cell population and proliferation. J Neurosci 25: 5774-5783.
16. Park IK, Qian D, Kiel M, Becker MW, Pihalja M, et al.(2003) Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423: 302-305.
17. Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, et al.(2006) Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66: 6063-6071.
18. Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A, et al.(1999) Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev 13: 2678-2690.
19. Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M, (1999) The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397: 164-168.
20. Vonlanthen S, Heighway J, Altermatt HJ, Gugger M, Kappeler A, et al.(2001) The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br J Cancer 84: 1372-1376.
21. Shakhova O, Leung C, Marino S, (2005) Bmi1 in development and tumorigenesis of the central nervous system. J Mol Med 83: 596-600.
22. Haupt Y, Bath ML, Harris AW, Adams JM, (1993) bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis. Oncogene 8: 3161-3164.
23. Bruggeman SW, Hulsman D, Tanger E, Buckle T, Blom M, et al.(2007) Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma. Cancer Cell 12: 328-341.
24. Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, et al.(2008) Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 68: 9125-9130.
25. Doble BW, Woodgett JR, (2003) GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116: 1175-1186.
26. Cohen P, Goedert M, (2004) GSK3 inhibitors: development and therapeutic potential. Nat Rev Drug Discov 3: 479-487.
27. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, et al.(2000) Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406: 86-90.
28. Ougolkov AV, Fernandez-Zapico ME, Savoy DN, Urrutia RA, Billadeau DD, (2005) Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells. Cancer Res 65: 2076-2081.
29. Tan J, Zhuang L, Leong HS, Iyer NG, Liu ET, et al.(2005) Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells. Cancer Res 65: 9012-9020.
30. Ryder J, Su Y, Liu F, Li B, Zhou Y, et al.(2003) Divergent roles of GSK3 and CDK5 in APP processing. Biochem Biophys Res Commun 312: 922-929.
31. Cline GW, Johnson K, Regittnig W, Perret P, Tozzo E, et al.(2002) Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats. Diabetes 51: 2903-2910.
32. Gould TD, Manji HK, (2002) The Wnt signaling pathway in bipolar disorder. Neuroscientist 8: 497-511.
33. Wang Z, Smith KS, Murphy M, Piloto O, Somervaille TC, et al.(2008) Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy. Nature.
34. Ishii N, Maier D, Merlo A, Tada M, Sawamura Y, et al.(1999) Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol 9: 469-479.
35. Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, et al.(2007) CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67: 4010-4015.
36. Pfenninger CV, Roschupkina T, Hertwig F, Kottwitz D, Englund E, et al.(2007) CD133 is not present on neurogenic astrocytes in the adult subventricular zone, but on embryonic neural stem cells, ependymal cells, and glioblastoma cells. Cancer Res 67: 5727-5736.
37. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, et al.(2004) Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64: 7011-7021.
38. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, et al.(2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9: 391-403.
39. Molofsky AV, He S, Bydon M, Morrison SJ, Pardal R, (2005) Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev 19: 1432-1437.
40. Molofsky AV, Slutsky SG, Joseph NM, He S, Pardal R, et al.(2006) Increasing p16(INK4a) expression decreases forebrain progenitors and neurogenesis during ageing. Nature.
41. Labuhn M, Jones G, Speel EJ, Maier D, Zweifel C, et al.(2001) Quantitative real-time PCR does not show selective targeting of p14(ARF) but concomitant inactivation of both p16(INK4A) and p14(ARF) in 105 human primary gliomas. Oncogene 20: 1103-1109.
42. Hemmings BA, Yellowlees D, Kernohan JC, Cohen P, (1981) Purification of glycogen synthase kinase 3 from rabbit skeletal muscle. Copurification with the activating factor (FA) of the (Mg-ATP) dependent protein phosphatase. Eur J Biochem 119: 443-451.
43. Foltz DR, Santiago MC, Berechid BE, Nye JS, (2002) Glycogen synthase kinase-3beta modulates notch signaling and stability. Curr Biol 12: 1006-1011.
44. Cohen Y, Chetrit A, Sirota P, Modan B, (1998) Cancer morbidity in psychiatric patients: influence of lithium carbonate treatment. Med Oncol 15: 32-36.
45. Wegner M, (1999) From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res 27: 1409-1420.
46. Gangemi RM, Griffero F, Marubbi D, Perera M, Capra MC, et al.(2008) SOX2 Silencing in Glioblastoma Tumor Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity. Stem Cells.
47. Fong H, Hohenstein KA, Donovan PJ, (2008) Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells. Stem Cells 26: 1931-1938.
48. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, et al.(2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40: 499-507.
49. Piccirillo SG, Vescovi AL, (2006) Bone morphogenetic proteins regulate tumorigenicity in human glioblastoma stem cells. Ernst Schering Found Symp Proc pp. 59-81.
50. Nowicki MO, Dmitrieva N, Stein AM, Cutter JL, Godlewski J, et al.(2008) Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3. Neuro Oncol 10: 690-699.
51. Kotliarova S, Pastorino S, Kovell LC, Kotliarov Y, Song H, et al.(2008) Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation. Cancer Res 68: 6643-6651.
52. Byfield MP, Murray JT, Backer JM, (2005) hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase. J Biol Chem 280: 33076-33082.
53. Nusse R, Fuerer C, Ching W, Harnish K, Logan C, et al.(2008) Wnt signaling and stem cell control. Cold Spring Harb Symp Quant Biol 73: 59-66.